JP2017530153A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017530153A5 JP2017530153A5 JP2017517700A JP2017517700A JP2017530153A5 JP 2017530153 A5 JP2017530153 A5 JP 2017530153A5 JP 2017517700 A JP2017517700 A JP 2017517700A JP 2017517700 A JP2017517700 A JP 2017517700A JP 2017530153 A5 JP2017530153 A5 JP 2017530153A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- range
- amount
- tsg
- pentraxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 104
- 239000000843 powder Substances 0.000 claims description 41
- 101001082142 Homo sapiens Pentraxin-related protein PTX3 Proteins 0.000 claims description 36
- 102100027351 Pentraxin-related protein PTX3 Human genes 0.000 claims description 36
- 102000007614 Thrombospondin 1 Human genes 0.000 claims description 32
- 108010046722 Thrombospondin 1 Proteins 0.000 claims description 32
- 239000000017 hydrogel Substances 0.000 claims description 28
- 239000000463 material Substances 0.000 claims description 24
- 239000002243 precursor Substances 0.000 claims description 24
- 239000003431 cross linking reagent Substances 0.000 claims description 16
- 102000008186 Collagen Human genes 0.000 claims description 14
- 108010035532 Collagen Proteins 0.000 claims description 14
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 14
- 229920001436 collagen Polymers 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 239000002195 soluble material Substances 0.000 claims description 14
- 230000029663 wound healing Effects 0.000 claims description 13
- 230000001939 inductive effect Effects 0.000 claims description 12
- 230000017423 tissue regeneration Effects 0.000 claims description 11
- 102000016942 Elastin Human genes 0.000 claims description 10
- 108010014258 Elastin Proteins 0.000 claims description 10
- 229920002549 elastin Polymers 0.000 claims description 10
- 239000004971 Cross linker Substances 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 6
- 230000004936 stimulating effect Effects 0.000 claims description 6
- 102000003390 tumor necrosis factor Human genes 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 4
- 210000001691 amnion Anatomy 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 229920001451 polypropylene glycol Polymers 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 claims description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 2
- 229920000936 Agarose Polymers 0.000 claims description 2
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 229920000463 Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) Polymers 0.000 claims description 2
- 229920002873 Polyethylenimine Polymers 0.000 claims description 2
- 108010039918 Polylysine Proteins 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229920001222 biopolymer Polymers 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 229940045110 chitosan Drugs 0.000 claims description 2
- 229960005188 collagen Drugs 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 229960002086 dextran Drugs 0.000 claims description 2
- 125000004386 diacrylate group Chemical group 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims description 2
- 229940099552 hyaluronan Drugs 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 229960000292 pectin Drugs 0.000 claims description 2
- 229920001983 poloxamer Polymers 0.000 claims description 2
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 claims description 2
- 229920002627 poly(phosphazenes) Polymers 0.000 claims description 2
- 229920000656 polylysine Polymers 0.000 claims description 2
- 229920000193 polymethacrylate Polymers 0.000 claims description 2
- 230000008929 regeneration Effects 0.000 claims description 2
- 238000011069 regeneration method Methods 0.000 claims description 2
- 229920001059 synthetic polymer Polymers 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- 238000000034 method Methods 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020188418A JP7486404B2 (ja) | 2014-10-02 | 2020-11-12 | 羊膜粉末ならびに創傷治癒および組織工学構築物におけるその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462058969P | 2014-10-02 | 2014-10-02 | |
| US62/058,969 | 2014-10-02 | ||
| PCT/US2015/053571 WO2016054423A1 (en) | 2014-10-02 | 2015-10-01 | Amniotic membrane powder and its use in wound healing and tissue engineering constructs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020188418A Division JP7486404B2 (ja) | 2014-10-02 | 2020-11-12 | 羊膜粉末ならびに創傷治癒および組織工学構築物におけるその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017530153A JP2017530153A (ja) | 2017-10-12 |
| JP2017530153A5 true JP2017530153A5 (enExample) | 2018-11-01 |
Family
ID=55631543
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017517700A Pending JP2017530153A (ja) | 2014-10-02 | 2015-10-01 | 羊膜粉末ならびに創傷治癒および組織工学構築物におけるその使用 |
| JP2020188418A Active JP7486404B2 (ja) | 2014-10-02 | 2020-11-12 | 羊膜粉末ならびに創傷治癒および組織工学構築物におけるその使用 |
| JP2022148694A Pending JP2022174265A (ja) | 2014-10-02 | 2022-09-20 | 羊膜粉末ならびに創傷治癒および組織工学構築物におけるその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020188418A Active JP7486404B2 (ja) | 2014-10-02 | 2020-11-12 | 羊膜粉末ならびに創傷治癒および組織工学構築物におけるその使用 |
| JP2022148694A Pending JP2022174265A (ja) | 2014-10-02 | 2022-09-20 | 羊膜粉末ならびに創傷治癒および組織工学構築物におけるその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12083245B2 (enExample) |
| EP (2) | EP4226929A1 (enExample) |
| JP (3) | JP2017530153A (enExample) |
| KR (2) | KR102516009B1 (enExample) |
| AU (2) | AU2015328014B2 (enExample) |
| CA (2) | CA2963273C (enExample) |
| DK (1) | DK3200809T3 (enExample) |
| ES (1) | ES2959455T3 (enExample) |
| WO (1) | WO2016054423A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5718459B2 (ja) | 2010-06-17 | 2015-05-13 | ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ | 整列した繊維を有する生物医学的パッチ |
| WO2012149486A1 (en) | 2011-04-28 | 2012-11-01 | Tissuetech, Inc. | Methods of modulating bone remodeling |
| CA2885682C (en) | 2012-09-21 | 2020-03-10 | Washington University | Biomedical patches with spatially arranged fibers |
| US10265438B1 (en) * | 2014-11-03 | 2019-04-23 | BioDlogics, LLC | Methods and compositions for the repair and replacement of connective tissue |
| US20160243288A1 (en) | 2015-02-23 | 2016-08-25 | Tissuetech, Inc. | Apparatuses and methods for treating ophthalmic diseases and disorders |
| US10342831B2 (en) | 2015-05-20 | 2019-07-09 | Tissuetech, Inc. | Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells |
| TW201733600A (zh) | 2016-01-29 | 2017-10-01 | 帝聖工業公司 | 胎兒扶持組織物及使用方法 |
| WO2019099860A2 (en) * | 2017-11-17 | 2019-05-23 | Medline Industries, Inc. | Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing |
| CN109394398B (zh) * | 2018-09-14 | 2019-10-18 | 江西瑞济生物工程技术股份有限公司 | 一种可降解的可折叠生物羊膜复合修复支架 |
| CN111330065A (zh) * | 2020-03-23 | 2020-06-26 | 动之医学技术(上海)有限公司 | 医用复合纤维、制备方法以及组织修复敷料 |
| US12201749B2 (en) | 2021-07-29 | 2025-01-21 | Acera Surgical, Inc. | Combined macro and micro-porous hybrid-scale fiber matrix |
| KR102620621B1 (ko) | 2021-09-14 | 2024-01-02 | 순천향대학교 산학협력단 | 양막 함유 창상피복재 조성물 |
| CN116077717B (zh) * | 2021-11-05 | 2024-01-30 | 重庆医科大学附属口腔医院 | 一种用于伤口愈合的生物荷载系统及其应用 |
| JP2023074268A (ja) * | 2021-11-17 | 2023-05-29 | ポーラ化成工業株式会社 | ＩＬ－１α発現抑制剤 |
| KR102439335B1 (ko) * | 2021-12-10 | 2022-09-02 | 주식회사 엠케이바이오텍 | 태반-유래 줄기세포를 함유하는 피부 재생용 바이오패치형 세포치료제 |
| CN114344549A (zh) * | 2021-12-13 | 2022-04-15 | 动之医学技术(上海)有限公司 | 复合羊膜敷料及其制备方法 |
| CN114225103A (zh) * | 2021-12-31 | 2022-03-25 | 湖北省银丰鼎诚生物工程有限公司 | 一种羊膜-氧化石墨烯水凝胶医用生物敷料 |
| EP4395797A4 (en) | 2022-06-29 | 2025-09-03 | Biostem Tech Inc | MICRONIZED WOUND HEALING COMPOSITIONS PREPARED FROM INTACT HUMAN AMNION-CHORION TISSUES HAVING AN INTACT INTERMEDIATE SPONGE LAYER POSITIONED BETWEEN THEM |
| NL2034251B1 (en) | 2023-03-02 | 2024-09-09 | Biostem Tech Inc | Human umbilical cord composition for treatment of peyronie's disease |
| WO2024151724A1 (en) | 2023-01-11 | 2024-07-18 | Biostem Technologies, Inc. | Human umbilical cord composition for use in the treatment of peyronie's disease |
| CN115845141B (zh) * | 2023-03-02 | 2023-05-16 | 健诺维(成都)生物科技有限公司 | 一种干态羊膜的制备方法及应用 |
| CN120837429A (zh) * | 2025-09-24 | 2025-10-28 | 湖南格致生物科技有限公司 | 一种羊膜水凝胶的制备方法及羊膜水凝胶 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4001944A (en) | 1975-08-25 | 1977-01-11 | Parke, Davis & Company | Freeze-drying process |
| US5514378A (en) | 1993-02-01 | 1996-05-07 | Massachusetts Institute Of Technology | Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures |
| US6323219B1 (en) | 1998-04-02 | 2001-11-27 | Ortho-Mcneil Pharmaceutical, Inc. | Methods for treating immunomediated inflammatory disorders |
| AU745302B2 (en) | 1998-05-23 | 2002-03-21 | Bieniarz, Andre | Method of treatment for premature rupture of membranes in pregnancy (PROM) |
| US20040048798A1 (en) | 1999-06-01 | 2004-03-11 | Raitano Arthur B. | Nucleic acid and corresponding protein entitle 98P4B6 useful in treatment and detection of cancer |
| AU3347000A (en) * | 1999-01-19 | 2000-08-01 | Children's Hospital Of Philadelphia, The | Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof |
| CN1227040C (zh) | 2001-09-05 | 2005-11-16 | 韩士生科有限公司 | 组织修复的生物材料及其制备方法 |
| US20100254900A1 (en) | 2002-03-18 | 2010-10-07 | Campbell Phil G | Biocompatible polymers and Methods of use |
| US20030187515A1 (en) | 2002-03-26 | 2003-10-02 | Hariri Robert J. | Collagen biofabric and methods of preparing and using the collagen biofabric |
| WO2004026244A2 (en) | 2002-09-18 | 2004-04-01 | Emiliano Ghinelli | Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin |
| AU2004208821B2 (en) | 2003-01-31 | 2009-01-15 | Zimmer Orthobiologics Inc. | Hydrogel compositions comprising nucleus pulposus tissue |
| KR20070015519A (ko) | 2004-03-11 | 2007-02-05 | 아르브라스트 가부시키가이샤 | 생체 조직 시트, 그것의 제조 방법, 및 그것을 이용한 이식방법 |
| DE602005020754D1 (de) | 2004-03-31 | 2010-06-02 | Cook Inc | Transplantatmaterial und gefässprothese mit extrazellulärer kollagenmatrix und dessen herstellungsverfahren |
| US7968085B2 (en) | 2004-07-05 | 2011-06-28 | Ascendis Pharma A/S | Hydrogel formulations |
| ATE514491T1 (de) | 2004-11-29 | 2011-07-15 | Dsm Ip Assets Bv | Verfahren zur verringerung der menge von migrierbaren komponenten von polymerbeschichtungen |
| WO2006094247A2 (en) | 2005-03-02 | 2006-09-08 | Tissuetech, Inc. | Amniotic membrane extracts, compositions thereof, and methods of use |
| JP5505760B2 (ja) * | 2005-09-27 | 2014-05-28 | ティッシュテク・インコーポレーテッド | 羊膜調製物及び精製組成物及びその使用方法 |
| US8372437B2 (en) | 2006-08-17 | 2013-02-12 | Mimedx Group, Inc. | Placental tissue grafts |
| WO2008060377A2 (en) | 2006-10-04 | 2008-05-22 | Anthrogenesis Corporation | Placental or umbilical cord tissue compositions |
| NZ612094A (en) | 2006-10-06 | 2015-02-27 | Anthrogenesis Corp | Native (telopeptide) placental collagen compositions |
| US8709081B2 (en) | 2006-10-23 | 2014-04-29 | Stemedica Cell Technologies, Inc. | Cellular scaffold |
| EP4559488A3 (en) | 2007-09-07 | 2025-08-13 | MiMedx Group, Inc. | Placental tissue grafts and improved methods of preparing and using the same |
| WO2009134414A2 (en) | 2008-04-30 | 2009-11-05 | The Board Of Trustees Of The Leland Stanford Junior University | Devices for the treatment of wounds and methods and kits thereof |
| US20110219462A1 (en) * | 2008-07-15 | 2011-09-08 | Bayer Schering Pharma Aktiengesellschaft | G-Protein Coupled Receptor 30 (GPR30) transgenic animals as a model for cardiovascular diseases |
| EP2341953B1 (en) | 2008-09-04 | 2018-11-21 | The General Hospital Corporation | Hydrogels for vocal cord and soft tissue augmentation and repair |
| SG2014012918A (en) | 2009-02-11 | 2014-04-28 | Novozymes Biopharma Dk As | Albumin variants and conjugates |
| KR20120115602A (ko) | 2010-01-26 | 2012-10-18 | 안트로제네시스 코포레이션 | 태반 줄기 세포를 사용한 골 관련 암의 치료 |
| KR101132625B1 (ko) | 2010-02-03 | 2012-04-02 | 주식회사 바이오랜드 | 콘택트 렌즈 형태의 양막 드레싱의 제조 방법 |
| EP2536827B1 (en) | 2010-02-18 | 2018-01-10 | Osiris Therapeutics, Inc. | Methods of manufacture of therapeutic products comprising vitalized placental dispersions |
| JP6081358B2 (ja) | 2010-09-01 | 2017-02-15 | トラスティーズ・オブ・タフツ・カレッジＴｒｕｓｔｅｅｓ Ｏｆ Ｔｕｆｔｓ Ｃｏｌｌｅｇｅ | 絹フィブロインおよびポリエチレングリコールをベースとする生体材料 |
| WO2012149486A1 (en) | 2011-04-28 | 2012-11-01 | Tissuetech, Inc. | Methods of modulating bone remodeling |
| US9393263B2 (en) * | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
| CA2837878A1 (en) | 2011-06-10 | 2012-12-13 | Tissuetech, Inc. | Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof |
| CA2844115C (en) * | 2011-08-26 | 2021-11-23 | Tissuetech, Inc. | Methods of sterilizing fetal support tissues |
| US9585983B1 (en) | 2011-10-12 | 2017-03-07 | BioDlogics, LLC | Wound covering and method of preparation |
| US8932805B1 (en) | 2011-10-31 | 2015-01-13 | BioDlogics, LLC | Birth tissue material and method of preparation |
| EP2785360B1 (en) | 2011-12-02 | 2019-06-19 | MIMEDX Group Inc. | Placental tissue grafts produced by chemical dehydration/freeze-drying and methods for making and using same |
| WO2013095830A1 (en) | 2011-12-22 | 2013-06-27 | Mimedx Group Inc. | Cross-linked dehydrated placental tissue grafts and methods for making and using the same |
| GB201201751D0 (en) | 2012-02-01 | 2012-03-14 | Haemostatix Ltd | Haemostatic wound dressing |
| US8904664B2 (en) | 2012-08-15 | 2014-12-09 | Mimedx Group, Inc. | Dehydration device and methods for drying biological materials |
| EP2897625B1 (en) | 2012-09-10 | 2019-10-23 | Wake Forest University Health Sciences | Amniotic membrane and its use in wound healing and tissue engineering constructs |
| CA2826786A1 (en) * | 2012-09-17 | 2014-03-17 | Confluent Surgical, Inc. | Multi-encapsulated formulations made with oxidized cellulose |
| US20140106447A1 (en) | 2012-10-12 | 2014-04-17 | Mimedx Group, Inc. | Compositions and methods for recruiting stem cells |
| BR112015013125A2 (pt) * | 2012-12-07 | 2017-07-11 | Anthrogenesis Corp | tratamento de lesões orais usando composições de matrix placentário extracelular |
| US9814746B2 (en) | 2014-06-15 | 2017-11-14 | Amnio Technology Llc | Method of treatment utilizing an acellular amnion derived therapeutic composition |
| TW201603818A (zh) | 2014-06-03 | 2016-02-01 | 組織科技股份有限公司 | 組成物及方法 |
| JP6960333B2 (ja) | 2014-09-09 | 2021-11-05 | ミメディクス グループ インコーポレイテッド | 任意にシーラントを含む微粒子化胎盤組織の組成物、ならびにその組成物の作製方法および使用方法 |
| TW201628633A (zh) | 2014-11-05 | 2016-08-16 | 組織科技股份有限公司 | 用於促進神經生長及再生之組成物及方法 |
| US10342831B2 (en) | 2015-05-20 | 2019-07-09 | Tissuetech, Inc. | Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells |
-
2015
- 2015-10-01 US US15/515,049 patent/US12083245B2/en active Active
- 2015-10-01 EP EP23173999.6A patent/EP4226929A1/en active Pending
- 2015-10-01 WO PCT/US2015/053571 patent/WO2016054423A1/en not_active Ceased
- 2015-10-01 CA CA2963273A patent/CA2963273C/en active Active
- 2015-10-01 EP EP15847740.6A patent/EP3200809B1/en active Active
- 2015-10-01 AU AU2015328014A patent/AU2015328014B2/en active Active
- 2015-10-01 DK DK15847740.6T patent/DK3200809T3/da active
- 2015-10-01 CA CA3209485A patent/CA3209485A1/en active Pending
- 2015-10-01 KR KR1020177011991A patent/KR102516009B1/ko active Active
- 2015-10-01 ES ES15847740T patent/ES2959455T3/es active Active
- 2015-10-01 KR KR1020237010448A patent/KR20230050467A/ko not_active Ceased
- 2015-10-01 JP JP2017517700A patent/JP2017530153A/ja active Pending
-
2020
- 2020-11-12 JP JP2020188418A patent/JP7486404B2/ja active Active
-
2021
- 2021-02-11 AU AU2021200873A patent/AU2021200873B2/en active Active
-
2022
- 2022-09-20 JP JP2022148694A patent/JP2022174265A/ja active Pending
-
2024
- 2024-08-05 US US18/794,181 patent/US20250213747A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017530153A5 (enExample) | ||
| JP7486404B2 (ja) | 羊膜粉末ならびに創傷治癒および組織工学構築物におけるその使用 | |
| US10850003B2 (en) | In-situ cross-linkable polymeric compositions and methods thereof | |
| KR101121480B1 (ko) | 미세다공성 입자를 포함하는 의학적으로 유용한 겔의 형성 및 사용 방법 | |
| ES2992920T3 (en) | Tissue repair membrane adapted for adhesion and lubrication, and methods for preparing the same | |
| JP2022001268A (ja) | 癒着予防のためのハイドロゲル膜 | |
| RU2012122334A (ru) | Композиция полисахаридного геля, обладающего многоступенчатой доставкой биоактивных веществ | |
| JP2013532139A5 (enExample) | ||
| KR101303284B1 (ko) | 히알루론산과 콘드로이틴 설페이트를 함유한 수화겔 및 이의 제조방법 | |
| RU2519220C1 (ru) | Местное гемостатическое средство | |
| CN114522270B (zh) | 止血粉的制备方法 | |
| CZ302380B6 (cs) | Suchá substance hydrogelu pro krytí ran a zpusob její prípravy | |
| KR20250038886A (ko) | 혈관내피성장인자를 포함하는 창상 치료용 마이크로비드 및 이의 제조방법 | |
| CN120478713A (zh) | 一种负载柑橘类黄酮的水凝胶伤口敷料及其制备方法 | |
| CN107596433A (zh) | 一种具有快速吸液和止血性能的止血粉的制备方法 | |
| PL235903B1 (pl) | Wieloskładnikowy system dozębodołowy | |
| NZ723969A (en) | In-situ cross-linkable polymeric compositions and methods thereof | |
| HK1135609B (en) | Formation of medically useful gels comprising microporous particles and methods of use |